CHRP research in the news
December 14, 2016: When bars offered self-service drinking water, breathalyzers showed lower blood alcohol content among patrons. Results could help HIV prevention efforts.
November 1, 2016: The Southern California HIV Policy Research Center today released a new policy brief that will help consumers better understand the cost of accessing pre-exposure prophylaxis (PrEP) through Covered California health plans. Open enrollment for Covered California, the State’s health insurance marketplace, begins today.
November 1, 2016: The Fellows Program provides policy research training and education to individuals who are affiliated with HIV/AIDS community-based organizations in California that serve people living with or populations disproportionately affected by HIV/AIDS. The two-year fellowship program will increase the capacity of community-based organizations to address the HIV epidemic in California by shaping public policy.
September 12, 2016: Majority of participants in a statewide survey were interested in taking PrEP, but less than 10% had ever used it; black and Latino men faced more barriers to accessing PrEP
June 28, 2016: CHRP announcess disparities grants
April 25, 2016: UC launches first culturally-appropriate PrEP demonstration project in the U.S.
April 25, 2016: UC launches first in the nation demonstration project
May 5, 2014
A demonstration project aimed at improving patient care for people with HIV and AIDS has reduced the number of hospital re-admissions at one Bay Area hospital by 44 percent. The new approach puts primary care physicians at the helm of an integrated care team that includes social workers, psychologists and medical specialists. These collaborative teams form virtual "patient-centered medical homes" that work together to ensure that patients come to appointments, take their medications and get the care they need.
New research from UC San Francisco and the San Francisco AIDS Foundation has found that clients participating in a harm-reduction substance use treatment program, the Stonewall Project, decrease their use of stimulants, such as methamphetamine, and reduce their sexual risk behavior.
The number of people nationwide who are newly infected with HIV, the virus that can cause AIDS, has held steady at about 50,000 annually in recent years after dropping sharply in the late 1980s, despite health professionals' best efforts to tackle the problem. "There is a degree of frustration -- we don't seem to be able to reduce the level of transmission," said George Lemp, director of the California HIV/AIDS Research Program. "A lot of people felt that we needed more aggressive approaches." The program will award $18 million in grants over four years to teams in Oakland, Los Angeles and San Diego to test a new approach that includes distributing Truvada to high-risk groups.
East Bay Renew Efforts To Reduce HIV Infection
June 20, 2013
Oakland is ground zero for an ambitious effort aimed at reducing the rate of HIV infection in young gay men of color. Clinical trials are underway of an FDA-approved therapy for prevention of HIV infection. Since January of 2010 the Downtown Youth Clinic has kept busy. The daily anti-retroviral medication is Truvada by Gilead, which was approved last year by the FDA. The California HIV/AIDS research program is funding the service.
Researchers identify possible key to slow progression toward AIDS
September 19, 2012
One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all. Even among those with the B57 gene, the speed of disease progression can vary considerably. Now, a group of investigators from the Multi-Center AIDS Cohort Study (MACS), housed within the UCLA AIDS Institute, may have uncovered the key to this variation.
California to test HIV-prevention pill
April 17, 2012
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state. The pill, which is already used to treat HIV patients, will be prescribed to 700 gay and bisexual men and transgender women in Los Angeles, San Diego and Long Beach who are high-risk but not infected. "With this new prevention pill, we have another intervention to put in the arsenal to try and impact this epidemic," said George Lemp, director of the California HIV/AIDS Research Program with the UC president's office.
Considering TLC+ In California: Proceedings of a Think Tank on HIV Testing, Linkage to Care, Plus Treatment
Nov. 10, 2010
In May 2010, the California HIV/AIDS Research Program (CHRP) and the California Coalition of Local AIDS Directors (CCLAD) co-sponsored a statewide think tank called Considering TLC+ in California. The specific goals of TLC+ (Testing and Linkage to Care Plus Treatment) are twofold: to increase the number of HIV-positive people who know their serostatus and are engaged in care and treatment to improve their individual health outcomes and to reduce the incidence of HIV infection.
Sixty-four planners, policymakers, treatment and care providers attended the meeting. TLC+proceedings report (pdf)